Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

60 Degrees Pharmaceuticals (SXTP) Net Margin (2022 - 2025)

Historic Net Margin for 60 Degrees Pharmaceuticals (SXTP) over the last 4 years, with Q3 2025 value amounting to 529.48%.

  • 60 Degrees Pharmaceuticals' Net Margin rose 11498000.0% to 529.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 872.75%, marking a year-over-year increase of 8212500.0%. This contributed to the annual value of 1387.57% for FY2024, which is 1601400.0% up from last year.
  • Latest data reveals that 60 Degrees Pharmaceuticals reported Net Margin of 529.48% as of Q3 2025, which was up 11498000.0% from 1718.91% recorded in Q2 2025.
  • In the past 5 years, 60 Degrees Pharmaceuticals' Net Margin ranged from a high of 7992.11% in Q3 2023 and a low of 15148.79% during Q1 2023
  • Moreover, its 4-year median value for Net Margin was 1439.25% (2025), whereas its average is 1769.68%.
  • Examining YoY changes over the last 5 years, 60 Degrees Pharmaceuticals' Net Margin showed a top increase of 154409100bps in 2024 and a maximum decrease of -96713900bps in 2024.
  • Over the past 4 years, 60 Degrees Pharmaceuticals' Net Margin (Quarter) stood at 4457.05% in 2022, then crashed by -137bps to 1652.82% in 2023, then soared by 45bps to 902.08% in 2024, then soared by 41bps to 529.48% in 2025.
  • Its last three reported values are 529.48% in Q3 2025, 1718.91% for Q2 2025, and 1225.67% during Q1 2025.